‘Senate votes to repeal key Biden administration vaccine and testing policy’ -Earlier Washington Post Report
https://www.washingtonpost.com/us-policy/2021/12/08/republicans-vaccine-congress-coronavirus/
The Daily Biotech Pulse: Adcom Backs Merck’s Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case
Here's a roundup of top developments in the biotech space over the last 24 hours:
Quidel Q3 EPS $5.36 Beats $3.52 Estimate, Sales $509.74M Beat $376.81M Estimate
Quidel (NASDAQ:QDEL) reported quarterly earnings of $5.36 per share which beat the analyst consensus estimate of $3.52 by 52.27 percent. This is a 7.27 percent decrease over earnings of $5.78 per share from the same
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Quidel Clocks Interim Q3 Sales Twice Of Wall Street Expected
Quidel Corporation (NASDAQ:QDEL) announced preliminary estimates for its Q3 revenues are expected to rise between 6% and 7% Y/Y on COVID-19…
After the Jobs Report, Investors are Looking at The Fed for Tapering Signals
Investors were in wait-and-see mode before the Employment Situation Report and then the volatility hit. Non-farm job growth was expected to be around 500,000 but the number was only 194,000. This shows how difficult predicting job growth has been during the pandemic.
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 7)